Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-014926
Filing Date
2025-04-22
Accepted
2025-04-22 16:36:30
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-22

Document Format Files

Seq Description Document Type Size
1 ARS ny20045184x3_ars.pdf ARS 1928572
  Complete submission text file 0001140361-25-014926.txt   2657610
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39630 | Film No.: 25858190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)